Available Until 2/4/2025

Intensive Studies for Recertification: Critical Care Pharmacy (Cert # L249015)

ACPE Numbers: Various -- see listing below
Content Release Date:
Expiration Date: 02/04/2025
Activity Type: Application-based
CE Credits: 4.5 contact hours (ACPE and BPS)
Activity Fee: $105 (ASHP member); $160 (non-member)

Activity Overview

These activities were presented as part of the 2023 Midyear Clinical Meeting. Learners who claimed ACPE credit for these activities as part of that meeting should not claim ACPE credit again.

The Intensive Study Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in critical care pharmacy. 

The Critical Care Pharmacy Intensive Study Recertification Package consists of 3 activities (see table below) and provides up to 4.5 contact hours of continuing pharmacy education and/or recertification credit.   

These activities are part of the ASHP professional development program for BCCCP recertification approved by BPS. For pharmacists who maintain more than one certification, all activities are approved for multiple specialties (see table below).

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • Procedural sedation
  • Drug allergy management
  • Recognition and treatment of hyperactive delirium with severe agitation

Board certified pharmacists are eligible to receive up to 4.5 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the content and successfully complete the online assessments by the deadline.

ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.

ASHP is approved by BPS as a provider for the recertification of BCCCP.

Learning Activity

Passing Score

Credit Information

Dream of the Endless: Updates in Procedural Sedation 


1.5 Contact Hours

ACPE: 0204-0000-23-309-H01-P

Making the Grade: Approaches to Drug Allergy Management


1.5 Contact Hours

ACPE: 0204-0000-23-239-H01-P

Dazed and Confused: Clearing the Haze for the Recognition and Treatment of Hyperactive Delirium with Severe Agitation


1.5 Contact Hours


ACPE: 0204-0000-23-265-H01-P

Dream of the Endless: Updates in Procedural Sedation
ACPE #: 0204-0000-23-309-H01-P

  • Evaluate the most current literature regarding agents used for sedation and analgesia in the setting of procedural sedation.
  • Discuss patient-specific variables that have the potential to impact the safety and efficacy of the various pharmacotherapy options used in procedural sedation.
  • Critique procedural sedation pharmacotherapy implementation strategies with the goal of optimizing pharmacokinetic and pharmacodynamic principles.
  • Recognize options for alternative routes of administration and potential considerations based on patient-specific factors.
  • Identify important components that should be included in workflows and protocols for procedural sedation (e.g., stocking atomizers for intranasal administration, antidote availability, bedside monitoring).

This activity is approved for Board Certified Pediatric Pharmacy Specialist (BCPPS) and Board Certified Critical Care Pharmacist (BCCCP) recertification credit. 

Making the Grade: Approaches to Drug Allergy Management
ACPE #: 0204-0000-23-239-H01-P

  • Compare and contrast skin testing, graded challenges, and desensitization as approaches to drug allergy management.
  • Evaluate current literature on drug allergy management approaches and their impact on patient outcomes.
  • Design an appropriate care plan given the results of a patient's allergy assessment.

This activity is approved for Board Certified Critical Care Pharmacist (BCCCP), Board Certified Pediatric Pharmacy Specialist (BCPPS), and Board Certified Pharmacotherapy Specialist (BCPS) recertification credit. 

Dazed and Confused: Clearing the Haze for the Recognition and Treatment of Hyperactive Delirium with Severe Agitation
ACPE #: 0204-0000-23-265-H01-P

  • Evaluate strategies that the care team can employ to promptly recognize a patient presenting with hyperactive delirium with severe agitation, as well as potential causes of the delirium.
  • Recommend an effective treatment regimen for the management of a patient presenting with hyperactive delirium with severe agitation.
  • Develop monitoring strategies for the medications used for hyperactive delirium with severe agitation.
  • Design an effective protocol or institutional guidelines to ensure patient and staff safety throughout transitions of care for patients presenting with hyperactive delirium with severe agitation.

This activity is approved for Board Certified Pharmacotherapy Specialist (BCPS) and Board Certified Critical Care Pharmacist (BCCCP) recertification credit.

Faculty bios

Abby M. Bailey, PharmD, BCCCP
Coordinator, Emergency Medicine
University of Kentucky HealthCare
Lexington, Kentucky

Robbie L. Christian, PharmD, AAHIVP, BCIDP
Infectious Diseases Clinical Pharmacy Specialist / ID PGY2 Residency Program Director
VA Northeast Ohio Health Care
Cleveland, Ohio

Yewande Dayo, PharmD, BCIDP
System Antimicrobial Stewardship Clinical Pharmacist
Ochsner Health
New Orleans, Louisiana

Rena A. Gosser, PharmD, BCPS, FASHP
Assistant Director, Specialty Pharmacy Services and Medication Access
University of Washington Medicine
Clinical Assistant Professor
University of Washington School of Pharmacy
Seattle, Washington 

Jennifer L. Koehl, PharmD, BCPS
Emergency Medicine Clinical Specialist
Massachusetts General Hospital
Boston, Massachusetts 

Megan E. Musselman, PharmD, MS, BCCCP, BCPS
Clinical Pharmacy Specialist, Emergency Medicine/PGY2 Emergency Medicine Pharmacy Residency Program Director
North Kansas City Hospital
Kansas City, Missouri

Kyle Weant, PharmD, BCPS, BCCCP, FCCP
Clinical Assistant Professor and Emergency Medicine Clinical Pharmacy Specialist
University of South Carolina College of Pharmacy
Columbia, South Carolina

Sue Dombrowski, MS, RPh
Snehal H. Bhatt, PharmD, AACC, BCPS-AQ Cardiology, FASHP*
Peter N. Johnson, PharmD, BCPPS, BCPS, FCCM, FPPAG*
Paul M. Szumita, PharmD, BCCCP, BCPS, FASHP, FCCM*
Jennifer L. Thackray, PharmD, BCPPS, BCPS*

*Content Matter Experts

Hakeem Abayomi, PharmD, BS, BCPS, BCPPS, BCIDP, BCCCP
Uzma Ahmed, PharmD, BCCCP
Edward Alvarez, PharmD, BCIDP, BCCCP
Neha Belter, PharmD, BCPS
Tiffany Boehland, PharmD, BCPS
Eugene Bush, BSPharm, PhD, Pharmacol, BCPS, BCCCP
Emily Chen, PharmD, BCPPS
Aaron Cooper, PharmD BCPPS
Adamma Davis, PharmD, BCPS, BCNSP
Chris DeMella, PharmD, BCCCPS
Emily Deremiah, PharmD, BCCCP
Milouse Dornevil, PharmD, BCPS, BCNSP
Andrea Dunlop, PharmD, BCPS
Ahmed Eid, PharmD, BCPS
Charisa Flaherty, PharmD, BCPPS
Parna Haghparast, PharmD, BCPS
Yorika Hammett, PharmD, BCCCP
Aaron Harthan, PharmD, BCPPS
Laila Hasham, PharmD
Stacy Henry, PharmD, BCPS
Rebecca Hilton, PharmD, BCCCP
Mylinh Ho, PharmD, BCPS, BCCCP
Allyson Howard, PharmD, BCPS
Miranda Howland, Pharm D, BCCCP
Sheena Jindal, PharmD, MS, BCPS
Jason Jones, BCPS, BCCCP
Bethany Jumps, PharmD, BCPS
Savannah Knepper, BCPS
Emily Kurzen, PharmD, BCPPS
Noelle Kwan, PharmD, BCPS
Nancy Laux, BSPharm, PharmD BCPS BCGP
Daisy Leong, PharmD, BCPS, BCSCP
Steven Lo, PharmD, BCPS
Melanie Madorsky, PharmD, BCPS, BCCP, BCCCP
Oussayma Moukhachen, PharmD, BCPS, BCCCP
Ria Lei Marie Natividad, PharmD, BCPS, CPh
Zoon Park, PharmD
Brittany Parker, PharmD, BCPS, CPPS
Dipti Patel, PharmD, BCCCP, BCIDP, BCPS
Angela Paul, PharmD, BCPS
Amanda Penland, PharmD, BCPPS
Inna Perinskaya, PharmD, BCCCP
Tracy Peterson, PharmD, BCPS, BCCCP
Bambi Randall, PharmD, BCPS
Antonio Rivera, PharmD, BCPS, MBA
Gabriella Sarver, PharmD, BCPS, BCCCP
Kanan Shah, PharmD, MBA, BCPS, BCCCP, CPPS
Bridger Singer, PharmD, BCPS, BCCCP
Melissa Sterling, PharmD, BCCCP
Bovornpat Suriyapakorn, PharmD, BCPS, BCGP
Yen Tang, PharmD, BCPS
Elizabeth Tesch, PharmD, BCPS, BCCP
Tyler Vest, PharmD, MS, BCPS, BCSCP, FNCAP
Anh Vu, PharmD, BCPS, BCCCP
Chelsea Wampole, PharmD, BCCCP
Stephanie Weightman, PharmD, BCPS, BCPPS, BCEMP
Corrie Weiland, PharmD, MBA, BCPS
Stephanie Yang, PharmD, BCPS
Rachel Zander, PharmD, BCPS
Barbara Zarowitz, PharmD, BCPS, BCGP

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP.